Actinium Pharmaceuticals
ATNM
ATNM
64 hedge funds and large institutions have $45M invested in Actinium Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $46.1M → $45M (-$1.13M)
27% less call options, than puts
Call options by funds: $1.62M | Put options by funds: $2.2M
Holders
64
Holding in Top 10
–
Calls
$1.62M
Puts
$2.2M
Top Buyers
| 1 | +$1.68M | |
| 2 | +$1.58M | |
| 3 | +$1.19M | |
| 4 |
Jane Street
New York
|
+$991K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$902K |
Top Sellers
| 1 | -$2.23M | |
| 2 | -$2.1M | |
| 3 | -$1.59M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.23M |
| 5 |
Two Sigma Advisers
New York
|
-$996K |